OBJECTIVE: Patients with diabetes experience increased cardiovascular complications after cardiac surgery. Hyperglycaemia predicts increased mortality after myocardial infarction and may influence cardiovascular risk in humans. Impaired prosurvival phosphatase and tensin homologue on chromosome 10 (PTEN)-Akt signalling could be an important feature of the diabetic heart rendering it resistant to preconditioning. This study was designed to evaluate for differences and relationships of myocardial PTEN-Akt-related signalling and baseline glycaemic control marker in type 2 diabetic and nondiabetic patients undergoing coronary artery bypass surgery. METHODS: Right atrial biopsies and coronary sinus blood were obtained from 18 type 2 diabetic and 18 nondiabetic patients intraoperatively. Expression and phosphorylation of Akt, endothelial nitric oxide synthase (eNOS), Bcl-2 and PTEN were evaluated by Western blot. Plasma 15-F(2t) -isoprostane concentrations were evaluated by liquid chromatography-mass spectrometry. RESULTS: PTEN expression and 15-F(2t) -isoprostane concentrations were significantly higher in diabetic patients. Increased fasting blood glucose levels correlated with increased coronary sinus plasma 15-F(2t) -isoprostane concentrations. Increased cardiac 15-F(2t) -isoprostane generation was highly correlated with myocardial PTEN expression. Bcl-2 expression and eNOS phosphorylation were significantly lower in diabetic compared with nondiabetic patients. Akt phosphorylation tended to be lower in diabetic patients; however, this tendency failed to reach statistical significance. CONCLUSION: The current results suggest that prosurvival PTEN-Akt signalling is impaired in the diseased diabetic myocardium. Hyperglycaemia and increased oxidative stress may contribute to this phenomenon. These findings strengthen the understanding of the underlying biologic mechanisms of cardiac injury in diabetic patients, which could facilitate development of new treatments to prevent cardiovascular complications in this high-risk population.
OBJECTIVE:Patients with diabetes experience increased cardiovascular complications after cardiac surgery. Hyperglycaemia predicts increased mortality after myocardial infarction and may influence cardiovascular risk in humans. Impaired prosurvival phosphatase and tensin homologue on chromosome 10 (PTEN)-Akt signalling could be an important feature of the diabetic heart rendering it resistant to preconditioning. This study was designed to evaluate for differences and relationships of myocardial PTEN-Akt-related signalling and baseline glycaemic control marker in type 2 diabetic and nondiabeticpatients undergoing coronary artery bypass surgery. METHODS: Right atrial biopsies and coronary sinus blood were obtained from 18 type 2 diabetic and 18 nondiabeticpatients intraoperatively. Expression and phosphorylation of Akt, endothelial nitric oxide synthase (eNOS), Bcl-2 and PTEN were evaluated by Western blot. Plasma 15-F(2t) -isoprostane concentrations were evaluated by liquid chromatography-mass spectrometry. RESULTS:PTEN expression and 15-F(2t) -isoprostane concentrations were significantly higher in diabeticpatients. Increased fasting blood glucose levels correlated with increased coronary sinus plasma 15-F(2t) -isoprostane concentrations. Increased cardiac 15-F(2t) -isoprostane generation was highly correlated with myocardial PTEN expression. Bcl-2 expression and eNOS phosphorylation were significantly lower in diabetic compared with nondiabeticpatients. Akt phosphorylation tended to be lower in diabeticpatients; however, this tendency failed to reach statistical significance. CONCLUSION: The current results suggest that prosurvival PTEN-Akt signalling is impaired in the diseased diabetic myocardium. Hyperglycaemia and increased oxidative stress may contribute to this phenomenon. These findings strengthen the understanding of the underlying biologic mechanisms of cardiac injury in diabeticpatients, which could facilitate development of new treatments to prevent cardiovascular complications in this high-risk population.
Authors: Franz Kehl; John G Krolikowski; Boris Mraovic; Paul S Pagel; David C Warltier; Judy R Kersten Journal: Anesthesiology Date: 2002-01 Impact factor: 7.892
Authors: S Pugazhenthi; A Nesterova; C Sable; K A Heidenreich; L M Boxer; L E Heasley; J E Reusch Journal: J Biol Chem Date: 2000-04-14 Impact factor: 5.157
Authors: Arun Samidurai; Ramzi Ockaili; Chad Cain; Sean K Roh; Scott M Filippone; Donatas Kraskauskas; Rakesh C Kukreja; Anindita Das Journal: iScience Date: 2020-11-26
Authors: Anna C Roberts; Jai Gohil; Laura Hudson; Kyle Connolly; Philip Warburton; Rakesh Suman; Peter O'Toole; David J O'Regan; Neil A Turner; Kirsten Riches; Karen E Porter Journal: J Diabetes Res Date: 2015-04-08 Impact factor: 4.011
Authors: Zhongju Lu; Ya-Ping Jiang; Chia-Yen C Wu; Lisa M Ballou; Shengnan Liu; Eileen S Carpenter; Michael R Rosen; Ira S Cohen; Richard Z Lin Journal: Diabetes Date: 2013-08-23 Impact factor: 9.461